Finix 20 (Tablet)

 

Finix 20

(Tablet)

Generics: Rabeprazole Sodium 20mg

Opsonin Pharma Ltd.

price/7.00 tk

Symptoms (Indications)

Rabeprazole is prescribed for duodenal ulcer healing, erosive or ulcerative Gastroesophageal Reflux Disease (GERD) healing, symptomatic GERD treatment, maintenance of healing of erosive or ulcerative GERD, Zollinger-Ellison Syndrome, and Helicobacter pylori eradication to reduce the risk of Duodenal Ulcer recurrence.

Pharmacology

Rabeprazole Sodium acts as a gastric proton-pump inhibitor, suppressing gastric acid secretion by inhibiting the gastric H+/K+-ATPase.

Dosage

The recommended dosage of Rabeprazole Sodium varies for different conditions: 20 mg once daily in the morning for active duodenal ulcer and active benign gastric ulcer, 20 mg once daily for 4-8 weeks for erosive or ulcerative GERD, 20 mg or 10 mg once daily for GERD maintenance depending on patient response, starting with a 60 mg once-daily dose for Zollinger-Ellison Syndrome and titrating upwards based on individual needs, and a combination therapy involving rabeprazole sodium 20 mg twice daily for 7 days for H. pylori eradication.

Administration

Should be taken in the morning before eating, and swallowed whole without chewing or crushing.

Interaction

Possible interaction with compounds pH-dependent absorption.

Co-administration with ketoconazole or itraconazole may decrease antifungal plasma levels.

Avoid co-administration with atazanavir.

Contraindications

Hypersensitivity to the active ingredient or any excipient.

Not recommended during pregnancy or nursing.

Side Effects

Generally well-tolerated; possible side effects include headache, diarrhea, abdominal discomfort, vomiting, constipation, dry mouth, increased or decreased appetite, muscle soreness, sleepiness, and dizziness.

Pregnancy & Lactation

FDA pregnancy category 'C'. Caution is advised during breastfeeding.

Precautions & Warnings

Symptomatic response does not exclude the presence of gastric or esophageal malignancy.

Regular surveillance for long-term treatment.

Risk of fractures, especially in the elderly.

Caution in patients with hepatic impairment.

Hypomagnesemia and interference with vitamin B12 absorption.

Subacute cutaneous lupus erythematosus (SCLE) association.

Interference with laboratory tests (Chromogranin A level).

Therapeutic Class

Proton Pump Inhibitor

Storage Conditions

Below 30°C, avoid direct sunlight, and keep away from children.

Pharmaceutical Name

Opsonin Pharma Ltd.

Related Products

Xorel 20

Prompton

Rmax 20

Rabe-20